Vicapsys Life Sciences, Inc.

OTC: VICP · Healthcare · Biotechnology

PublicHQ Cumming, GA · ForsythCIK 0001468639Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 50

v0.1 · 5/100 weight · pillars only

↑ listing tenure, market scale · ↓ Altman-Z, return on assets

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.2M

Employees

Market cap

$47.3M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$1.2M-$1.2M2023

Operating income-$1.0M-$1.0M2023

Total assets$39.7k$39.7k2023

Equity-$1.9M-$1.9M2023

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Vicapsys Life Sciences, Inc. earned -$1.2M in FY2023 net income.

Peers · Healthcare

Horizon Space Acquisition II Corp.——Metagenomi, Inc. Common Stock39D PDS Biotechnology Corporation——Decibel Cannabis Company Inc.62C

Key facts

CEOFederico Pier

SectorHealthcare

IndustryBiotechnology

HeadquartersCumming, GA

ExchangeOTC: VICP

Employees2

IPO date1998-02-23

Latest filings

10-Q2025-01-10 10-Q2025-01-10 10-Q2025-01-10 10-K2024-10-21 8-K2023-12-27 10-Q2023-11-14 10-Q2023-08-14 8-K2023-06-30

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.